\-\ Texto\\:\\ \ \(0\)\
\-\ hcg\\ positive\\ \ \(0\)\
\-\ serum\\ estradiol\\ 2638\ \(0\)\
\-\ cbc\\:\\ \\ 16\\.5\\/16\\.6\\/48\\.8\\/312\ \(0\)\
\-\ unknown\\ at\\ time\\ of\\ submission\\.\\ \\ in\\ the\\ case\\ of\\ ovarian\\ hyperstimulation\\ syndrome\\ treatment\\ is\\ often\\ supportive\\ with\\ close\\ monitoring\\ of\\ blood\\ volume\\.\\ \\ pleural\\ effusions\\ can\\ be\\ drained\\ if\\ they\\ are\\ symptomatic\\.\ \(0\)\
\-\ bilateral\\ lung\\ opacities\\ with\\ blunting\\ of\\ costophrenic\\ angles\\ and\\ menisci\\ consistent\\ with\\ moderate\\ sized\\ pleural\\ effusions\\ and\\ bilateral\\ focal\\ areas\\ of\\ atelectasis\\ or\\ airspace\\ disease\\.\\ \\ \ \(0\)\
\-\ heart\\ size\\ difficult\\ to\\ assess\\ due\\ to\\ overlapping\\ pleural\\ opacities\\.\\ \\ \ \(0\)\
\-\ mild\\ thoracolumbar\\ dextroscoliosis\ \(0\)\
\-\ patient\\ has\\ pelvic\\ shielding\\ consistent\\ with\\ pregnancy\ \(0\)\
\-\ trachea\\ mid\\-line\\,\\ no\\ pneumothorax\\,\\ vasculature\\ not\\ enlarged\ \(0\)\
\-\ findings\\ are\\ new\\ when\\ compared\\ with\\ normal\\ cxr\\ in\\ 2006\\.\ \(0\)\
\-\ pleural\\ effusion\\ most\\ likely\\ caused\\ by\\ ovarian\\ hyperstimulation\\ syndrome\\;\\ however\\,\\ final\\ diagnosis\\ was\\ not\\ known\\ prior\\ to\\ submission\ \(0\)\
\-\ ovarian\\ hyperstimulation\\ syndrome\ \(1\)\
\-\ meigs\\ syndrome\ \(0\)\
\-\ cardiac\\,\\ liver\\,\\ or\\ renal\\ failure\ \(0\)\
\-\ infection\ \(713\)\
\-\ pulmonary\\ embolism\ \(77\)\
\-\ malignant\\ effusion\ \(1\)\
\-\ 31\\ year\\ old\\ female\\ g3p0020\\ who\\ is\\ day\\ 2\\ status\\ post\\ ivf\\ cycle\\ and\\ now\\ complains\\ of\\ difficulty\\ breathing\\.\ \(0\)\
\-\ work\\-up\\ for\\ ovarian\\ hyperstimulation\\ syndrome\\:\ \(0\)\
\-\ labs\\-hcg\\,\\ cbc\\,\\ chemistry\\,\\ lfts\\,\\ estradiol\\,\\ monitor\\ i\\/os\ \(0\)\
\-\ imaging\\:\\ \\ cxr\\,\\ ultrasound\\ of\\ ovaries\ \(0\)\
\-\ procedures\\:\\ \\ thoracentesis\\,\\ drain\\ pleural\\ fluid\ \(0\)\
\-\ discussion\\:\ \(1\)\
\-\ ovarian\\ hyperstimulation\\ syndrome\\ occurs\\ when\\ there\\ is\\ ovarian\\ enlargement\\ due\\ to\\ multiple\\ cysts\\ with\\ a\\ fluid\\ shift\\ out\\ of\\ the\\ intravascular\\ space\\.\\ \\ it\\ often\\ occurs\\ after\\ ovarian\\ stimulation\\ via\\ hcg\\/hmg\\ in\\ women\\ trying\\ to\\ conceive\\.\\ \\ other\\ risk\\ factors\\ are\\ pcos\\,\\ thyroid\\ disease\\,\\ age\\ \\<35\\,\\ pregnancy\\ or\\ previous\\ history\\ of\\ ohss\\.\\ \\ the\\ fluid\\ shift\\ is\\ thought\\ to\\ be\\ due\\ to\\ the\\ cysts\\ secreting\\ vasoactive\\ substances\\ which\\ leads\\ to\\ ascites\\ and\\ pleural\\ effusion\\.\\ \\ when\\ severe\\ this\\ syndrome\\ can\\ cause\\ renal\\ failure\\,\\ thrombosis\\,\\ hypovolemic\\ shock\\,\\ ards\\,\\ or\\ death\\.\\ \\ symptoms\\ usually\\ appear\\ 5\\-10\\ days\\ following\\ induction\\ of\\ ovulation\\ and\\ can\\ include\\ abdominal\\ pain\\,\\ nausea\\,\\ vomiting\\,\\ sob\\,\\ ascites\\.\\ \\ treatment\\ is\\ often\\ supportive\\ by\\ maintaining\\ intravascular\\ volume\\,\\ monitoring\\ i\\/os\\ and\\ providing\\ dvt\\ prophylaxis\\.\\ \\ pleural\\ effusions\\ can\\ be\\ drained\\ for\\ symptom\\ relief\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hyperstimulation\\:\\ 0\\.3647422930569156\ \(0\)\
\-\ ovarian\\:\\ 0\\.302407447725357\ \(0\)\
\-\ pleural\\:\\ 0\\.2672104247333797\ \(0\)\
\-\ syndrome\\:\\ 0\\.2139908064637838\ \(0\)\
\-\ estradiol\\:\\ 0\\.14589691722276624\ \(0\)\
\-\ hcg\\:\\ 0\\.1426684494403173\ \(0\)\
\-\ effusions\\:\\ 0\\.14236366666378505\ \(0\)\
\-\ submission\\:\\ 0\\.12413965639685905\ \(0\)\
\-\ intravascular\\:\\ 0\\.11955576376864904\ \(0\)\
\-\ drained\\:\\ 0\\.1152681913628831\ \(0\)\
\-\ effusion\\:\\ 0\\.11296482640567698\ \(0\)\
\-\ can\\:\\ 0\\.10644059943363335\ \(0\)\
\-\ ascites\\:\\ 0\\.10460764628008809\ \(0\)\
\-\ to\\:\\ 0\\.1014159573874284\ \(0\)\
\-\ monitoring\\:\\ 0\\.10113529068606146\ \(0\)\
\-\ often\\:\\ 0\\.09926163863513901\ \(0\)\
\-\ of\\:\\ 0\\.09923404956367386\ \(0\)\
\-\ opacities\\:\\ 0\\.09682724757937745\ \(0\)\
\-\ when\\:\\ 0\\.09189238184728402\ \(0\)\
\-\ volume\\:\\ 0\\.08910105693380221\ \(0\)\
\-\ shift\\:\\ 0\\.08910105693380221\ \(0\)\
\-\ fluid\\:\\ 0\\.08783369967030959\ \(0\)\
\-\ due\\:\\ 0\\.08744437592853847\ \(0\)\
\-\ supportive\\:\\ 0\\.0847304058638554\ \(0\)\
\-\ cbc\\:\\ 0\\.08461680291002295\ \(0\)\
\-\ pregnancy\\:\\ 0\\.0829945108670677\ \(0\)\
\-\ cxr\\:\\ 0\\.08113166666204596\ \(0\)\
\-\ 2638\\:\\ 0\\.0810937342602504\ \(0\)\
\-\ meigs\\:\\ 0\\.0810937342602504\ \(0\)\
\-\ g3p0020\\:\\ 0\\.0810937342602504\ \(0\)\
\-\ ohss\\:\\ 0\\.0810937342602504\ \(0\)\
\-\ occurs\\:\\ 0\\.07996099362062906\ \(0\)\
\-\ shielding\\:\\ 0\\.07748939236672969\ \(0\)\
\-\ vasoactive\\:\\ 0\\.07748939236672969\ \(0\)\
\-\ hypovolemic\\:\\ 0\\.07748939236672969\ \(0\)\
\-\ failure\\:\\ 0\\.07699767734883178\ \(0\)\
\-\ cysts\\:\\ 0\\.07685074426637559\ \(0\)\
\-\ dextroscoliosis\\:\\ 0\\.07493207109538565\ \(0\)\
\-\ pcos\\:\\ 0\\.07493207109538565\ \(0\)\
\-\ substances\\:\\ 0\\.07493207109538565\ \(0\)\
\-\ ovulation\\:\\ 0\\.07294845861138312\ \(0\)\
\-\ or\\:\\ 0\\.07056216586905437\ \(0\)\
\-\ conceive\\:\\ 0\\.06995742201117107\ \(0\)\
\-\ is\\:\\ 0\\.06943416793651982\ \(0\)\
\-\ induction\\:\\ 0\\.06772338730834422\ \(0\)\
\-\ overlapping\\:\\ 0\\.06678679544651836\ \(0\)\
\-\ chemistry\\:\\ 0\\.06678679544651836\ \(0\)\
\-\ thoracentesis\\:\\ 0\\.06678679544651836\ \(0\)\
\-\ maintaining\\:\\ 0\\.06593954504918928\ \(0\)\
\-\ ivf\\:\\ 0\\.06379575884630631\ \(0\)\
\-\ ards\\:\\ 0\\.06379575884630631\ \(0\)\
\-\ trying\\:\\ 0\\.06318245355299763\ \(0\)\
\-\ secreting\\:\\ 0\\.06318245355299763\ \(0\)\
\-\ renal\\:\\ 0\\.06315507865064295\ \(0\)\
\-\ and\\:\\ 0\\.0628695918684134\ \(0\)\
\-\ providing\\:\\ 0\\.06206982819842952\ \(0\)\
\-\ be\\:\\ 0\\.06171108416072931\ \(0\)\
\-\ angles\\:\\ 0\\.061081098938514294\ \(0\)\
\-\ menisci\\:\\ 0\\.061081098938514294\ \(0\)\
\-\ thoracolumbar\\:\\ 0\\.05977788188432452\ \(0\)\
\-\ with\\:\\ 0\\.05957600513078519\ \(0\)\
\-\ blunting\\:\\ 0\\.05938273234649512\ \(0\)\
\-\ lfts\\:\\ 0\\.05864151979765106\ \(0\)\
\-\ costophrenic\\:\\ 0\\.05829287115517793\ \(0\)\
\-\ cycle\\:\\ 0\\.05829287115517793\ \(0\)\
\-\ shock\\:\\ 0\\.05829287115517793\ \(0\)\
\-\ are\\:\\ 0\\.05772456874094624\ \(0\)\
\-\ ovaries\\:\\ 0\\.055908165033564765\ \(0\)\
\-\ stimulation\\:\\ 0\\.055908165033564765\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.055908165033564765\ \(0\)\
\-\ consistent\\:\\ 0\\.054990492265948876\ \(0\)\
\-\ bilateral\\:\\ 0\\.054505106105914004\ \(0\)\
\-\ airspace\\:\\ 0\\.05446346911678885\ \(0\)\
\-\ dvt\\:\\ 0\\.05322106918163036\ \(0\)\
\-\ sob\\:\\ 0\\.0524798566327863\ \(0\)\
\-\ sized\\:\\ 0\\.05179571908509399\ \(0\)\
\-\ monitor\\:\\ 0\\.05179571908509399\ \(0\)\
\-\ symptom\\:\\ 0\\.05163260623545722\ \(0\)\
\-\ leads\\:\\ 0\\.05116049170695982\ \(0\)\
\-\ drain\\:\\ 0\\.05056764534303073\ \(0\)\
\-\ vasculature\\:\\ 0\\.04987819910548725\ \(0\)\
\-\ final\\:\\ 0\\.049746501868700006\ \(0\)\
\-\ procedures\\:\\ 0\\.049746501868700006\ \(0\)\
\-\ death\\:\\ 0\\.049746501868700006\ \(0\)\
\-\ breathing\\:\\ 0\\.04961672728810964\ \(0\)\
\-\ trachea\\:\\ 0\\.04911578344368893\ \(0\)\
\-\ treatment\\:\\ 0\\.04831018138933314\ \(0\)\
\-\ relief\\:\\ 0\\.04755614981343911\ \(0\)\
\-\ assess\\:\\ 0\\.04686822873689989\ \(0\)\
\-\ embolism\\:\\ 0\\.04596954482544842\ \(0\)\
\-\ close\\:\\ 0\\.04588447813905353\ \(0\)\
\-\ women\\:\\ 0\\.04563405592022923\ \(0\)\
\-\ serum\\:\\ 0\\.04547094307059246\ \(0\)\
\-\ atelectasis\\:\\ 0\\.045153430715264065\ \(0\)\
\-\ 31\\:\\ 0\\.04499882854209507\ \(0\)\
\-\ discussion\\:\\ 0\\.04440598217816597\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.04419347641977673\ \(0\)\
\-\ complains\\:\\ 0\\.04412375527106189\ \(0\)\
\-\ thought\\:\\ 0\\.043783123524570186\ \(0\)\
\-\ by\\:\\ 0\\.04306743575769303\ \(0\)\
\-\ factors\\:\\ 0\\.04289344153884148\ \(0\)\
\-\ difficulty\\:\\ 0\\.04265478557043336\ \(0\)\
\-\ disease\\:\\ 0\\.042571150571712735\ \(0\)\
\-\ difficult\\:\\ 0\\.042084756932551\ \(0\)\
\-\ via\\:\\ 0\\.041445722530422224\ \(0\)\
\-\ thrombosis\\:\\ 0\\.04134354438370695\ \(0\)\
\-\ compared\\:\\ 0\\.04099489574123382\ \(0\)\
\-\ caused\\:\\ 0\\.040659406836014635\ \(0\)\
\-\ 35\\:\\ 0\\.040659406836014635\ \(0\)\
\-\ the\\:\\ 0\\.040472634546626834\ \(0\)\
\-\ not\\:\\ 0\\.04003692212212416\ \(0\)\
\-\ appear\\:\\ 0\\.03993702777068054\ \(0\)\
\-\ thyroid\\:\\ 0\\.03985072222972417\ \(0\)\
\-\ pelvic\\:\\ 0\\.03963855461922822\ \(0\)\
\-\ symptomatic\\:\\ 0\\.03899176755039931\ \(0\)\
\-\ nausea\\:\\ 0\\.038952864202129976\ \(0\)\
\-\ enlargement\\:\\ 0\\.03887556457685969\ \(0\)\
\-\ unknown\\:\\ 0\\.03842537213318779\ \(0\)\
\-\ previous\\:\\ 0\\.03831629836116236\ \(0\)\
\-\ moderate\\:\\ 0\\.03806687997056922\ \(0\)\
\-\ in\\:\\ 0\\.037843795595702674\ \(0\)\
\-\ cardiac\\:\\ 0\\.03765494213522566\ \(0\)\
\-\ vomiting\\:\\ 0\\.03752176509915777\ \(0\)\
\-\ they\\:\\ 0\\.03623207719411269\ \(0\)\
\-\ risk\\:\\ 0\\.03623207719411269\ \(0\)\
\-\ malignant\\:\\ 0\\.03614673829014672\ \(0\)\
\-\ status\\:\\ 0\\.035387425656878586\ \(0\)\
\-\ heart\\:\\ 0\\.035258404511122894\ \(0\)\
\-\ new\\:\\ 0\\.0350808642125644\ \(0\)\
\-\ liver\\:\\ 0\\.03498098225284755\ \(0\)\
\-\ now\\:\\ 0\\.03480884462995688\ \(0\)\
\-\ enlarged\\:\\ 0\\.03456857592553352\ \(0\)\
\-\ cause\\:\\ 0\\.03454490240717038\ \(0\)\
\-\ areas\\:\\ 0\\.03442747136139126\ \(0\)\
\-\ size\\:\\ 0\\.03433463082151311\ \(0\)\
\-\ space\\:\\ 0\\.033753709538123566\ \(0\)\
\-\ positive\\:\\ 0\\.03341421621782176\ \(0\)\
\-\ out\\:\\ 0\\.03333133076053489\ \(0\)\
\-\ known\\:\\ 0\\.032830104385534555\ \(0\)\
\-\ day\\:\\ 0\\.03230036634353387\ \(0\)\
\-\ severe\\:\\ 0\\.032100596118686264\ \(0\)\
\-\ days\\:\\ 0\\.032100596118686264\ \(0\)\
\-\ usually\\:\\ 0\\.03192280217423184\ \(0\)\
\-\ age\\:\\ 0\\.03183522116144723\ \(0\)\
\-\ ultrasound\\:\\ 0\\.03127786822212667\ \(0\)\
\-\ pulmonary\\:\\ 0\\.0309090935749811\ \(0\)\
\-\ lung\\:\\ 0\\.03084649190153201\ \(0\)\
\-\ for\\:\\ 0\\.030738639868842343\ \(0\)\
\-\ infection\\:\\ 0\\.03063079394909467\ \(0\)\
\-\ following\\:\\ 0\\.030420206076557876\ \(0\)\
\-\ focal\\:\\ 0\\.03033145924070385\ \(0\)\
\-\ likely\\:\\ 0\\.03030207276471366\ \(0\)\
\-\ include\\:\\ 0\\.03017102271229506\ \(0\)\
\-\ time\\:\\ 0\\.03005613386410215\ \(0\)\
\-\ however\\:\\ 0\\.03001343049507111\ \(0\)\
\-\ if\\:\\ 0\\.02946282723140284\ \(0\)\
\-\ blood\\:\\ 0\\.029449489793204525\ \(0\)\
\-\ mild\\:\\ 0\\.02874513728704867\ \(0\)\
\-\ who\\:\\ 0\\.028683788521183005\ \(0\)\
\-\ prior\\:\\ 0\\.028371426083236142\ \(0\)\
\-\ symptoms\\:\\ 0\\.027744751493369624\ \(0\)\
\-\ abdominal\\:\\ 0\\.027733756561984537\ \(0\)\
\-\ post\\:\\ 0\\.02759204637325881\ \(0\)\
\-\ imaging\\:\\ 0\\.026648968264598963\ \(0\)\
\-\ most\\:\\ 0\\.026390174975497067\ \(0\)\
\-\ other\\:\\ 0\\.02633367435589219\ \(0\)\
\-\ diagnosis\\:\\ 0\\.026286863289891146\ \(0\)\
\-\ it\\:\\ 0\\.0259569095037123\ \(0\)\
\-\ case\\:\\ 0\\.02547533725768817\ \(0\)\
\-\ findings\\:\\ 0\\.025026618032596298\ \(0\)\
\-\ multiple\\:\\ 0\\.024802570867148047\ \(0\)\
\-\ after\\:\\ 0\\.02459946499923254\ \(0\)\
\-\ female\\:\\ 0\\.024469130784229916\ \(0\)\
\-\ has\\:\\ 0\\.023162109150101223\ \(0\)\
\-\ which\\:\\ 0\\.023057603600961915\ \(0\)\
\-\ normal\\:\\ 0\\.020703890364384806\ \(0\)\
\-\ there\\:\\ 0\\.02017670588397604\ \(0\)\
\-\ history\\:\\ 0\\.019373535604500173\ \(0\)\
\-\ at\\:\\ 0\\.01915319598931417\ \(0\)\
\-\ pain\\:\\ 0\\.0181453234683079\ \(0\)\
\-\ was\\:\\ 0\\.01767237146268976\ \(0\)\
\-\ this\\:\\ 0\\.01742431156141632\ \(0\)\
\-\ patient\\:\\ 0\\.016492889458905452\ \(0\)\
\-\ no\\:\\ 0\\.016489787242544678\ \(0\)\
\-\ year\\:\\ 0\\.015627323465653955\ \(0\)\
\-\ old\\:\\ 0\\.015007640059291498\ \(0\)\
